John snow Creó nuevo artículo
5 D - Traducciones

Neurofibromatosis Type 2 Pipeline | #neurofibromatosis Type 2 Pipeline

Neurofibromatosis Type 2 Pipeline

Neurofibromatosis Type 2 Pipeline

Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics